Teckro raises $10m to advance clinical trial digitization

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/CarlosAndreSantos)
(Image: iStock/CarlosAndreSantos)

Related tags: Clinical trial

Teckro Inc has raised $10m in Series B financing as the company aims to expand the digitization of clinical trials.

To date, the company has raised $17.8m. The latest funding round was led by Sands Capital Ventures with participation from Bill Maris’ Section 32 venture fund, Founders Fund, and private investors.

Gary Hughes, CEO and co-founder of Teckro told Outsourcing-Pharma.com the funding will be used to advance development of the company’s platform, which uses information retrieval and machine learning technologies to improve clinical trial conduct.

We have a number of products in advanced development which will have an interesting data analytics dimension​,” added Hughes.

The funds will also be used to expand the company’s operations in the US and Asia and to onboard additional studies, Hughes said.

Our platform can support all types of trials through Phase I to IV but we are seeing most demand in the Phase II and Phase III space because the need for effective site engagement is so critical in these studies​,” he added.

We believe that technology should replace the burden in conducting clinical trials rather than add to it​,” said Hughes. “Technology should empower sites to do what they do best, that is, treating patients​.” 

Related news

Related products

show more

Paper vs ePRO Data Collection Methods

Paper vs ePRO Data Collection Methods

Signant Health | 19-Oct-2021 | Technical / White Paper

Are you curious why more Sponsors choose digital data collection methods over the traditional pen and paper? Read this recent white paper to discover the...

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us


View more